Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 409,602
  • Shares Outstanding, K 68,381
  • Annual Sales, $ 0 K
  • Annual Income, $ -118,460 K
  • 60-Month Beta 2.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.45
Trade CMPS with:

Options Overview Details

View History
  • Implied Volatility 88.01% ( +4.33%)
  • Historical Volatility 47.18%
  • IV Percentile 67%
  • IV Rank 49.50%
  • IV High 125.91% on 06/21/24
  • IV Low 50.86% on 06/29/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 529
  • Put/Call OI Ratio 1.47
  • Today's Open Interest 15,631
  • Open Int (30-Day) 11,987

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.53
  • Number of Estimates 4
  • High Estimate -0.44
  • Low Estimate -0.58
  • Prior Year -0.62
  • Growth Rate Est. (year over year) +14.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.73 +5.41%
on 06/27/24
7.94 -23.93%
on 06/04/24
-1.40 (-18.82%)
since 05/28/24
3-Month
5.73 +5.41%
on 06/27/24
10.31 -41.42%
on 04/04/24
-2.28 (-27.40%)
since 03/28/24
52-Week
5.01 +20.56%
on 11/13/23
12.75 -52.63%
on 02/28/24
-1.96 (-24.50%)
since 06/28/23

Most Recent Stories

More News
Should You Buy the Dip on Compass Pathways Stock?

Nothing is going wrong, but one of its peers just hit a serious snag.

CMPS : 6.04 (+0.83%)
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

Regulators were not impressed by one company's petition for approval.

CMPS : 6.04 (+0.83%)
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

Psychedelic medicines are rapidly gaining legitimacy on several fronts.

CMPS : 6.04 (+0.83%)
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2024.

CMPS : 6.04 (+0.83%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 146.16 (+0.25%)
CMPS : 6.04 (+0.83%)
MNMD : 7.21 (-0.55%)
ATAI : 1.3300 (+0.76%)
ABBV : 171.52 (+1.50%)
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 468.72 (-0.80%)
CMPS : 6.04 (+0.83%)
CPRX : 15.49 (+2.99%)
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript

CMPS earnings call for the period ending December 31, 2023.

CMPS : 6.04 (+0.83%)
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.

The lofty target is closer to being within reach than it may seem at first.

CMPS : 6.04 (+0.83%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 6.04 (+0.83%)
SEEL : 0.5970 (-2.10%)
ATAI : 1.3300 (+0.76%)
MNMD : 7.21 (-0.55%)
NUMI.TO : 0.0450 (unch)
NUMIF : 0.0325 (+0.31%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 6.04 (+0.83%)
SEEL : 0.5970 (-2.10%)
ATAI : 1.3300 (+0.76%)
MNMD : 7.21 (-0.55%)
NUMI.TO : 0.0450 (unch)
NUMIF : 0.0325 (+0.31%)

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 6.37
2nd Resistance Point 6.25
1st Resistance Point 6.15
Last Price 6.04
1st Support Level 5.92
2nd Support Level 5.80
3rd Support Level 5.69

See More

52-Week High 12.75
Fibonacci 61.8% 9.79
Fibonacci 50% 8.88
Fibonacci 38.2% 7.97
Last Price 6.04
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar